Sarda Proteins Ltd (SRDAPRT) — shareholding pattern, promoter holding, financials and share price
About Sarda Proteins Ltd (SRDAPRT)
Sarda Proteins Ltd operates in the Edible Oil industry, within the Fast Moving Consumer Goods sector. It trades on the NSE as SRDAPRT and on the BSE under scrip code 519242. Its ISIN is INE995U01011.
Incorporated in 1991, Sarda Proteins Ltd deals in the trading of Solar Cells [1]
Sarda Proteins Limited, established in 1991, trades in edible oils and agricultural commodities such as wheat and oil seeds.
In 2018-19, the company's management underwent a significant change as Ritika Vegetable Oil Private Limited acquired controlling interest, reshaping its strategic direction.
Listed peers in Edible Oil: Ambar Protein Industries Ltd, Prime Industries Ltd, Raj Oil Mills Ltd, Diligent Industries Ltd, Superior Industrial Enterprises Ltd, N K Industries Ltd.
Valuation & Returns
At ₹97.8 a share, Sarda Proteins Ltd (SRDAPRT) was valued at a price-to-earnings ratio of 132.68x against an industry P/E of 33.81x and a price-to-book of 8.81x on a book value of ₹10.57 per share. Solomo computes return on equity of 21.15% and return on capital employed of 20.12% from filed results.
- P/E
- 132.68x
- Industry P/E
- 33.81x
- P/B
- 8.81x
- EPS (TTM)
- ₹0.71
- Book value / share
- ₹10.57
- ROE
- 21.15%
- ROCE
- 20.12%
- ROA
- 0.73%
- Debt / equity
- 0.05x
- Dividend yield
- 0%
- EBITDA margin
- 3.9%
- 52-week range
- ₹59.95 – ₹144.3
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Sarda Proteins Ltd (SRDAPRT) reported revenue of ₹16.16 crore, net profit of ₹0.64 crore and earnings per share of ₹0.71. That compares with revenue of ₹24.19 crore and net profit of ₹0.01 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Jun 2026, revenue was ₹12.99 crore and net profit ₹1.66 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 10.76 | 5.8 | 1.3 | 24.19 | 16.16 |
| Net profit (₹ cr) | 0.31 | -0.03 | 0.02 | 0.01 | 0.64 |
| EPS (₹) | 1.8 | -0.17 | 0.12 | 0.06 | 0.71 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 31.47% | 34.97% | 31.00% | - |
| Profit growth | - | -31.13% | -74.50% | -50.00% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 80.66% of Sarda Proteins Ltd (SRDAPRT) (up 80.66 pp QoQ). Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Jun 2003.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 80.66% | - | - | - | 19.34% |
| Mar 2026 | 0% | - | - | - | 100% |
| Dec 2025 | 0% | - | - | - | 100% |
| Sep 2025 | 0% | - | - | - | 100% |
| Jun 2025 | 0% | - | - | - | 100% |
| Mar 2025 | 0% | - | - | - | 100% |
| Dec 2024 | 0% | - | - | - | 100% |
| Sep 2024 | 0% | - | - | - | 100% |